| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| DrugBank | |
| ChemSpider |
|
| UNII | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C26H41Br2NO4 |
| Molar mass | 591.425 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Pinaverium bromide (INN) is a medication used forfunctional gastrointestinal disorders. It belongs to a drug group calledantispasmodics and acts as acalcium channel blocker in helping to restore the normal contraction process of the bowel. It is most effective when taken for a full course of treatment and is not designed for immediate symptom relief or sporadic, intermittent use.[1]
Pinaverium bromide was first registered in 1975 bySolvay Pharmaceuticals (now a division ofAbbott Laboratories), and marketed globally using the brand namesDicetel andEldicet. Generic pinaverium is available in South Korea under a trade name ofDisten[2] and in Argentina asNulite.[3]
It is indicated for the treatment and relief of symptoms associated withirritable bowel syndrome (IBS) including abdominal pain, bowel disturbances and intestinal discomfort; and treatment of symptoms related to functional disorders of biliary tract.[4]